Vault-13

Integral Health Asset Management, LLC

New York, NY · CIK 1773206 · 13F filing filed 2022-08-03

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$486.2m reported value +26.5% vs Q1 2022
65positions
40.7%in top 10
15 new 40 added 9 reduced 21 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ELEVANCE HEALTH INC COM ELV ELV 67,840 $32.7m6.73% 6.73% AddedShares held: Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 45.0k, Q2 2022 67.8k +22.8k +22,840 50.8%
2 CENTENE CORP DEL COM CNC CNC 350,000 $29.6m6.09% 6.09% AddedShares held: Q3 2021 100.0k, Q4 2021 225.0k, Q1 2022 150.0k, Q2 2022 350.0k +200.0k +200,000 133.3%
3 ELI LILLY & CO COM LLY LLY 73,059 $23.7m4.87% 4.87% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 73.1k
4 CYTOKINETICS INC COM NEW CYTK CYTK 525,000 $20.6m4.24% 4.24% AddedShares held: Q3 2021 325.0k, Q4 2021 325.0k, Q1 2022 470.0k, Q2 2022 525.0k +55.0k +55,000 11.7%
5 SANOFI SPONSORED ADR SNY SNY 350,000 $17.5m3.60% 3.60% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 350.0k
6 GUARDANT HEALTH INC COM GH GH 385,291 $15.5m3.20% 3.20% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 100.0k, Q2 2022 385.3k +285.3k +285,291 285.3%
7 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 234,830 $15.5m3.19% 3.19% AddedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 234.8k +134.8k +134,830 134.8%
8 ENVISTA HOLDINGS CORPORATION COM NVST NVST 386,165 $14.9m3.06% 3.06% AddedShares held: Q3 2021 230.0k, Q4 2021 300.0k, Q1 2022 250.0k, Q2 2022 386.2k +136.2k +136,165 54.5%
9 CHEMOCENTRYX INC COM CCXI CCXI 574,029 $14.2m2.93% 2.93% AddedShares held: Q3 2021 300.0k, Q4 2021 200.0k, Q1 2022 400.0k, Q2 2022 574.0k +174.0k +174,029 43.5%
10 MCKESSON CORP COM MCK MCK 41,748 $13.6m2.80% 2.80% NewShares held: Q3 2021 0, Q4 2021 55.0k, Q1 2022 0, Q2 2022 41.7k
11 SAGE THERAPEUTICS INC COM SAGE SAGE 412,257 $13.3m2.74% 2.74% AddedShares held: Q3 2021 319.0k, Q4 2021 409.0k, Q1 2022 311.0k, Q2 2022 412.3k +101.3k +101,257 32.6%
12 TENET HEALTHCARE CORP COM NEW THC THC 250,485 $13.2m2.71% 2.71% AddedShares held: Q3 2021 0, Q4 2021 80.0k, Q1 2022 130.0k, Q2 2022 250.5k +120.5k +120,485 92.7%
13 CVS HEALTH CORP COM CVS CVS 140,898 $13.1m2.69% 2.69% AddedShares held: Q3 2021 150.0k, Q4 2021 85.0k, Q1 2022 90.0k, Q2 2022 140.9k +50.9k +50,898 56.5%
14 DEXCOM INC COM DXCM DXCM 166,991 $12.4m2.56% 2.56% NewShares held: Q3 2021 40.0k, Q4 2021 0, Q1 2022 0, Q2 2022 167.0k
15 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 126,286 $10.5m2.15% 2.15% AddedShares held: Q3 2021 18.0k, Q4 2021 48.0k, Q1 2022 80.0k, Q2 2022 126.3k +46.3k +46,286 57.9%
16 PERKINELMER INC COM RVTY RVTY 67,840 $9.6m1.98% 1.98% ReducedShares held: Q3 2021 50.0k, Q4 2021 70.0k, Q1 2022 75.0k, Q2 2022 67.8k -7.2k -7,160 -9.6%
17 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 340,243 $9.6m1.97% 1.97% AddedShares held: Q3 2021 90.0k, Q4 2021 120.0k, Q1 2022 215.0k, Q2 2022 340.2k +125.2k +125,243 58.2%
18 MERCK & CO INC COM MRK MRK 104,369 $9.5m1.96% 1.96% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 75.0k, Q2 2022 104.4k +29.4k +29,369 39.2%
19 SHOCKWAVE MED INC COM SWAV SWAV 46,966 $9.0m1.85% 1.85% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 30.0k, Q2 2022 47.0k +17.0k +16,966 56.5%
20 KURA ONCOLOGY INC COM KURA KURA 461,310 $8.5m1.74% 1.74% AddedShares held: Q3 2021 60.0k, Q4 2021 85.0k, Q1 2022 337.0k, Q2 2022 461.3k +124.3k +124,310 36.9%
21 ALKERMES PLC SHS ALKS ALKS 261,966 $7.8m1.61% 1.61% AddedShares held: Q3 2021 0, Q4 2021 50.0k, Q1 2022 250.0k, Q2 2022 262.0k +12.0k +11,966 4.8%
22 AMICUS THERAPEUTICS INC COM FOLD FOLD 704,490 $7.6m1.56% 1.56% AddedShares held: Q3 2021 425.0k, Q4 2021 175.0k, Q1 2022 224.0k, Q2 2022 704.5k +480.5k +480,490 214.5%
23 PERRIGO CO PLC SHS PRGO PRGO 182,645 $7.4m1.52% 1.52% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 182.6k
24 RELAY THERAPEUTICS INC COM RLAY RLAY 436,262 $7.3m1.50% 1.50% AddedShares held: Q3 2021 140.0k, Q4 2021 225.0k, Q1 2022 327.0k, Q2 2022 436.3k +109.3k +109,262 33.4%
25 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 46,966 $6.8m1.41% 1.41% NewShares held: Q3 2021 25.0k, Q4 2021 20.0k, Q1 2022 0, Q2 2022 47.0k
26 ICON PLC SHS ICLR ICLR 31,311 $6.8m1.40% 1.40% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 31.3k
27 UNIQURE NV SHS QURE QURE 353,106 $6.6m1.35% 1.35% AddedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 170.0k, Q2 2022 353.1k +183.1k +183,106 107.7%
28 BLUEPRINT MEDICINES CORP COM BPMC BPMC 130,000 $6.6m1.35% 1.35% ReducedShares held: Q3 2021 98.0k, Q4 2021 75.0k, Q1 2022 153.0k, Q2 2022 130.0k -23.0k -23,000 -15.0%
29 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 57,403 $6.2m1.28% 1.28% ReducedShares held: Q3 2021 0, Q4 2021 40.0k, Q1 2022 60.0k, Q2 2022 57.4k -2.6k -2,597 -4.3%
30 1LIFE HEALTHCARE INC COM COM 730,582 $5.7m1.18% 1.18% AddedShares held: Q3 2021 0, Q4 2021 275.0k, Q1 2022 500.0k, Q2 2022 730.6k +230.6k +230,582 46.1%
31 MODERNA INC COM MRNA MRNA 40,000 $5.7m1.18% 1.18% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 40.0k
32 SEAGEN INC COM SGEN SGEN 31,311 $5.5m1.14% 1.14% ReducedShares held: Q3 2021 40.0k, Q4 2021 0, Q1 2022 50.0k, Q2 2022 31.3k -18.7k -18,689 -37.4%
33 ZAI LAB LTD ADR ZLAB ZLAB 156,554 $5.4m1.12% 1.12% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 75.0k, Q2 2022 156.6k +81.6k +81,554 108.7%
34 AGILON HEALTH INC COM COM 230,655 $5.0m1.04% 1.04% AddedShares held: Q3 2021 180.0k, Q4 2021 125.0k, Q1 2022 175.0k, Q2 2022 230.7k +55.7k +55,655 31.8%
35 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 80,010 $4.9m1.00% 1.00% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 120.0k, Q2 2022 80.0k -40.0k -39,990 -33.3%
36 APELLIS PHARMACEUTICALS INC COM APLS APLS 99,150 $4.5m0.92% 0.92% AddedShares held: Q3 2021 190.0k, Q4 2021 120.0k, Q1 2022 39.8k, Q2 2022 99.2k +59.4k +59,381 149.3%
37 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 78,277 $4.5m0.92% 0.92% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 40.0k, Q2 2022 78.3k +38.3k +38,277 95.7%
38 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 41,748 $4.4m0.90% 0.90% AddedShares held: Q3 2021 60.0k, Q4 2021 0, Q1 2022 30.0k, Q2 2022 41.7k +11.7k +11,748 39.2%
39 INTELLIA THERAPEUTICS INC COM NTLA NTLA 83,495 $4.3m0.89% 0.89% AddedShares held: Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 83.5k +33.5k +33,495 67.0%
40 PTC THERAPEUTICS INC COM PTCT PTCT 104,656 $4.2m0.86% 0.86% AddedShares held: Q3 2021 97.1k, Q4 2021 45.0k, Q1 2022 42.0k, Q2 2022 104.7k +62.7k +62,656 149.2%
41 DAVITA INC COM DVA DVA 52,184 $4.2m0.86% 0.86% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 52.2k
42 TELADOC HEALTH INC COM TDOC TDOC 124,369 $4.1m0.85% 0.85% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 124.4k
43 ACLARIS THERAPEUTICS INC COM ACRS ACRS 285,971 $4.0m0.82% 0.82% AddedShares held: Q3 2021 185.0k, Q4 2021 200.0k, Q1 2022 238.0k, Q2 2022 286.0k +48.0k +47,971 20.2%
44 REPLIMUNE GROUP INC COM REPL REPL 219,194 $3.8m0.79% 0.79% AddedShares held: Q3 2021 90.0k, Q4 2021 100.0k, Q1 2022 165.0k, Q2 2022 219.2k +54.2k +54,194 32.8%
45 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 177,427 $3.5m0.71% 0.71% AddedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 140.0k, Q2 2022 177.4k +37.4k +37,427 26.7%
46 NEVRO CORP COM NVRO NVRO 78,277 $3.4m0.71% 0.71% AddedShares held: Q3 2021 30.0k, Q4 2021 35.0k, Q1 2022 50.0k, Q2 2022 78.3k +28.3k +28,277 56.5%
47 KRYSTAL BIOTECH INC COM KRYS KRYS 52,184 $3.4m0.70% 0.70% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 52.2k
48 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 20,874 $3.3m0.67% 0.67% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 35.0k, Q2 2022 20.9k -14.1k -14,126 -40.4%
49 ITEOS THERAPEUTICS INC COM ITOS ITOS 156,553 $3.2m0.66% 0.66% AddedShares held: Q3 2021 0, Q4 2021 50.0k, Q1 2022 85.0k, Q2 2022 156.6k +71.6k +71,553 84.2%
50 REATA PHARMACEUTICALS INC CL A RETA RETA 104,369 $3.2m0.65% 0.65% AddedShares held: Q3 2021 35.0k, Q4 2021 103.0k, Q1 2022 35.0k, Q2 2022 104.4k +69.4k +69,369 198.2%
51 XENON PHARMACEUTICALS INC COM XENE XENE 97,281 $3.0m0.61% 0.61% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 97.3k
52 HERON THERAPEUTICS INC COM HRTX HRTX 1,000,000 $2.8m0.57% 0.57% UnchangedShares held: Q3 2021 410.0k, Q4 2021 750.0k, Q1 2022 1.0m, Q2 2022 1.0m
53 AKERO THERAPEUTICS INC COM AKRO AKRO 288,058 $2.7m0.56% 0.56% AddedShares held: Q3 2021 85.0k, Q4 2021 85.0k, Q1 2022 200.0k, Q2 2022 288.1k +88.1k +88,058 44.0%
54 ARCTURUS THERAPEUTICS HLDGS COM ARCT ARCT 156,553 $2.5m0.51% 0.51% AddedShares held: Q3 2021 85.0k, Q4 2021 65.0k, Q1 2022 125.0k, Q2 2022 156.6k +31.6k +31,553 25.2%
55 NANOSTRING TECHNOLOGIES INC COM NSTG NSTG 188,500 $2.4m0.49% 0.49% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 188.5k
56 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 234,830 $2.3m0.47% 0.47% AddedShares held: Q3 2021 0, Q4 2021 140.0k, Q1 2022 171.0k, Q2 2022 234.8k +63.8k +63,830 37.3%
57 LIFESTANCE HEALTH GROUP INC COM LFST LFST 375,728 $2.1m0.43% 0.43% AddedShares held: Q3 2021 350.0k, Q4 2021 0, Q1 2022 150.0k, Q2 2022 375.7k +225.7k +225,728 150.5%
58 SI-BONE INC COM SIBN SIBN 157,317 $2.1m0.43% 0.43% ReducedShares held: Q3 2021 170.0k, Q4 2021 175.0k, Q1 2022 235.0k, Q2 2022 157.3k -77.7k -77,683 -33.1%
59 INSMED INC COM PAR $.01 INSM INSM 104,369 $2.1m0.42% 0.42% ReducedShares held: Q3 2021 100.0k, Q4 2021 80.0k, Q1 2022 150.0k, Q2 2022 104.4k -45.6k -45,631 -30.4%
60 ATARA BIOTHERAPEUTICS INC COM COM 208,738 $1.6m0.33% 0.33% ReducedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 300.0k, Q2 2022 208.7k -91.3k -91,262 -30.4%
61 FORMA THERAPEUTICS HLDGS INC SHS SHS 130,051 $896.0k0.18% 0.18% AddedShares held: Q3 2021 60.0k, Q4 2021 75.0k, Q1 2022 90.0k, Q2 2022 130.1k +40.1k +40,051 44.5%
62 CINCOR PHARMA INC COM COM 41,748 $787.0k0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 41.7k
63 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 300,000 $558.0k0.11% 0.11% NewShares held: Q3 2021 350.0k, Q4 2021 200.0k, Q1 2022 0, Q2 2022 300.0k
64 MAGENTA THERAPEUTICS INC COM COM 328,269 $394.0k0.08% 0.08% AddedShares held: Q3 2021 90.0k, Q4 2021 90.0k, Q1 2022 201.0k, Q2 2022 328.3k +127.3k +127,269 63.3%
65 LONGBOARD PHARMACEUTICALS IN COM COM 57,335 $177.0k0.04% 0.04% AddedShares held: Q3 2021 30.0k, Q4 2021 30.0k, Q1 2022 47.6k, Q2 2022 57.3k +9.7k +9,735 20.4%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
PFIZER INC PFE PFE 300,000 $15.5m300.0k shares
GLOBUS MED INC GMED GMED 180,000 $13.3m180.0k shares
ACADIA HEALTHCARE COMPANY IN ACHC ACHC 150,000 $9.8m150.0k shares
AMEDISYS INC AMED AMED 40,000 $6.9m40.0k shares
THE CIGNA GROUP CI CI 25,000 $6.0m25.0k shares
INTUITIVE SURGICAL INC ISRG ISRG 16,000 $4.8m16.0k shares
KEROS THERAPEUTICS INC KROS KROS 81,000 $4.4m81.0k shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 35,000 $3.3m35.0k shares
BIOGEN INC BIIB BIIB 15,000 $3.2m15.0k shares
REGENXBIO INC RGNX RGNX 90,000 $3.0m90.0k shares
TELEFLEX INCORPORATED TFX TFX 8,000 $2.8m8.0k shares
INSPIRE MED SYS INC INSP INSP 10,000 $2.6m10.0k shares
INTERCEPT PHARMACEUTICALS IN ICPT ICPT 125,000 $2.0m125.0k shares
DOXIMITY INC DOCS DOCS 30,000 $1.6m30.0k shares
INCYTE CORP INCY INCY 18,000 $1.4m18.0k shares
PRECISION BIOSCIENCES INC 350,000 $1.1m350.0k shares
PMV PHARMACEUTICALS INC PMVP PMVP 50,000 $1.0m50.0k shares
SIERRA ONCOLOGY INC 30,000 $962.0k30.0k shares
DENALI THERAPEUTICS INC DNLI DNLI 26,000 $836.0k26.0k shares
CHIMERIX INC CMRX CMRX 119,000 $545.0k119.0k shares
AVALO THERAPEUTICS INC 700,000 $507.0k700.0k shares